Skip to main content
Premium Trial:

Request an Annual Quote

Baylor and Rainbow Genomics Partner to Offer Exome Sequencing in Asia

NEW YORK (GenomeWeb) – Baylor Genetics and Rainbow Genomics announced on Monday a partnership to offer clinical exome sequencing tests to patients in Asia.

Hong Kong-based Rainbow Genomics will offer screening and diagnostic exome sequencing-based tests developed by Baylor, including one to assess risk for developing a genetic disorder, a test to assess cancer risk, and a diagnostic cancer test. In addition, Rainbow will use Baylor's Consultagene service to offer bilingual genetic counseling in English, Mandarin, Cantonese, and Japanese.

The two firms said that the tests cover more than 22,000 genes, including some that may be more specific to Asians, and may increase diagnostic yield. The geographies covered by the deal include Hong Kong, Japan, Singapore, and other countries in Asia.

Financial details of the agreement were not disclosed.

Christine Eng, Baylor Genetics' chief medical officer, said in a statement that the partnership "gives us the opportunity to serve a new patient population."

Rainbow CEO Daniel Siu added that the firm is "committed to bringing validated genetic tests supported by clear medical evidence to patients and physicians in local communities."

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.